BioSpace News Archive

InflaRx N.V. today announced that it has dosed its first healthy volunteer in a randomized, double-blind, placebo-controlled Phase I trial of orally administered, small molecule C5aR inhibitor INF904.

Crescita Therapeutics Inc. today reported its financial results for the third quarter ended September 30, 2022 (“Q3-F2022”).

Transcenta Holding Limited announces that the management team will collaborate with major brokerage firms and asset management firms to organize three exchange sessions in November 2022.

Amarin Corporation plc announced that Karim Mikhail, Amarin’s president and chief executive officer, is scheduled to participate at the Jefferies London Healthcare Conference.

Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company leveraging its Human-First Discovery® platform to develop a novel class of orally administered biological drugs, announced that the company will present at the following investor conferences.

Vaccitech plc announced that the Company’s Chief Executive Officer, Bill Enright, and Chief Financial Officer, Gemma Brown will be presenting at the following investment conferences in November.

Abata Therapeutics today announced that Samantha Singer, M.S., M.B.A., president, and chief executive officer, and John Trzupek, M.B.A., Ph.D., chief operating officer, will participate in a fireside chat at Guggenheim’s 4th Annual Immunology and Neurology Day on Monday, November 14, 2022, at 9:00 a.m. ET in New York, NY.

Scholar Rock today announced the appointment of Jing L. Marantz, M.D., Ph.D., M.B.A., as Chief Medical Officer.

Revance Therapeutics, Inc., a biotechnology company focused on innovative aesthetic and therapeutic offerings, announced that the company will participate in the Stifel 2022 Healthcare Conference, taking place November 15-16, 2022, in New York City.

Mentice has received a 3 million SEK grant from the Swedish government agency for innovation, Vinnova, to improve realism in Mentice virtual reality software environment with a focus on synthetic image generation.